Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stem Cells | 4 | 2024 | 3540 | 1.160 |
Why?
|
| Immune Evasion | 3 | 2024 | 377 | 0.750 |
Why?
|
| Hair Follicle | 2 | 2018 | 224 | 0.640 |
Why?
|
| Bowman Capsule | 1 | 2018 | 1 | 0.620 |
Why?
|
| Flow Cytometry | 4 | 2022 | 5881 | 0.570 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 92 | 0.560 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 1352 | 0.530 |
Why?
|
| Glomerulonephritis | 1 | 2018 | 332 | 0.520 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2024 | 4642 | 0.510 |
Why?
|
| Listeriosis | 1 | 2016 | 146 | 0.480 |
Why?
|
| Podocytes | 1 | 2018 | 391 | 0.450 |
Why?
|
| Tumor Escape | 3 | 2024 | 371 | 0.450 |
Why?
|
| Listeria monocytogenes | 1 | 2016 | 244 | 0.450 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3111 | 0.450 |
Why?
|
| Autoimmunity | 2 | 2024 | 1354 | 0.440 |
Why?
|
| Immunotherapy | 3 | 2024 | 4752 | 0.430 |
Why?
|
| Wound Healing | 1 | 2024 | 2792 | 0.410 |
Why?
|
| Neutrophils | 1 | 2024 | 3776 | 0.370 |
Why?
|
| Antigen Presentation | 6 | 2024 | 1250 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 548 | 0.360 |
Why?
|
| Intestines | 1 | 2020 | 1906 | 0.350 |
Why?
|
| MicroRNAs | 3 | 2016 | 3785 | 0.350 |
Why?
|
| Dendritic Cells | 3 | 2018 | 2747 | 0.330 |
Why?
|
| Lentivirus | 1 | 2012 | 518 | 0.320 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10261 | 0.320 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 583 | 0.310 |
Why?
|
| Skin | 2 | 2020 | 4489 | 0.290 |
Why?
|
| Mice, Transgenic | 8 | 2024 | 9550 | 0.280 |
Why?
|
| Liver | 5 | 2016 | 7562 | 0.280 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 1349 | 0.280 |
Why?
|
| Neoplasms | 4 | 2024 | 22340 | 0.270 |
Why?
|
| Prediabetic State | 1 | 2012 | 548 | 0.270 |
Why?
|
| Immunity, Innate | 3 | 2024 | 3081 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2495 | 0.250 |
Why?
|
| Hepatocytes | 1 | 2012 | 1247 | 0.240 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3946 | 0.230 |
Why?
|
| SOXF Transcription Factors | 1 | 2024 | 31 | 0.230 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2024 | 93 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2012 | 4137 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4405 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 2880 | 0.210 |
Why?
|
| Mitochondria | 1 | 2016 | 3673 | 0.200 |
Why?
|
| Animals | 21 | 2024 | 168764 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2631 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3513 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5849 | 0.180 |
Why?
|
| Mice | 16 | 2024 | 81819 | 0.180 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 42 | 0.180 |
Why?
|
| Ketones | 1 | 2021 | 183 | 0.170 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2021 | 202 | 0.170 |
Why?
|
| Furans | 1 | 2021 | 198 | 0.170 |
Why?
|
| Autoantigens | 1 | 2024 | 883 | 0.170 |
Why?
|
| Receptors, Progesterone | 2 | 2021 | 1153 | 0.160 |
Why?
|
| Phagocytes | 1 | 2021 | 292 | 0.160 |
Why?
|
| Thymus Gland | 1 | 2024 | 1261 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22332 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 3 | 2015 | 898 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2023 | 2485 | 0.140 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2017 | 61 | 0.140 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 17075 | 0.140 |
Why?
|
| Integrins | 1 | 2020 | 840 | 0.130 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2242 | 0.130 |
Why?
|
| Poly I-C | 1 | 2016 | 110 | 0.130 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 93 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2024 | 14448 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2476 | 0.120 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 21056 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1365 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2015 | 271 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2013 | 103 | 0.110 |
Why?
|
| Adenoma | 1 | 2024 | 2152 | 0.110 |
Why?
|
| Antigens | 1 | 2018 | 1438 | 0.100 |
Why?
|
| Muscles | 1 | 2018 | 1578 | 0.100 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 558 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 2002 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2017 | 718 | 0.100 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2013 | 197 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 169 | 0.100 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 497 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 705 | 0.100 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2011 | 10 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 2013 | 193 | 0.090 |
Why?
|
| Hydrolases | 1 | 2011 | 146 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 298 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10429 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2013 | 1644 | 0.090 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2593 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 1216 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1242 | 0.090 |
Why?
|
| DNA Replication | 1 | 2017 | 1433 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 910 | 0.080 |
Why?
|
| Point Mutation | 1 | 2014 | 1590 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2012 | 1144 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4209 | 0.080 |
Why?
|
| Humans | 19 | 2024 | 765968 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 2210 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2019 | 1539 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2867 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 582 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1718 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2014 | 1343 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4562 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1118 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2054 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2016 | 4025 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1106 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3797 | 0.060 |
Why?
|
| Fibrosis | 1 | 2012 | 2070 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 1936 | 0.060 |
Why?
|
| Inflammation | 1 | 2024 | 10850 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2014 | 1597 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2011 | 1341 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2024 | 3160 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 6942 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11868 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9373 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2021 | 23601 | 0.050 |
Why?
|
| Endoderm | 1 | 2024 | 165 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 7421 | 0.050 |
Why?
|
| Macrophages | 2 | 2021 | 5772 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6493 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2024 | 296 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 1995 | 0.050 |
Why?
|
| Disease Progression | 2 | 2024 | 13632 | 0.050 |
Why?
|
| Eosinophils | 1 | 2024 | 945 | 0.040 |
Why?
|
| Taxoids | 1 | 2022 | 665 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 741 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11022 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3985 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 1151 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 2018 | 170 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 735 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3446 | 0.040 |
Why?
|
| Organoids | 1 | 2024 | 739 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 975 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 204 | 0.040 |
Why?
|
| Female | 9 | 2024 | 396112 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 2014 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9525 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18973 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5891 | 0.030 |
Why?
|
| Interphase | 1 | 2017 | 226 | 0.030 |
Why?
|
| Genome, Human | 2 | 2021 | 4448 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5337 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2019 | 453 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 229 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1347 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3273 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2324 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 437 | 0.030 |
Why?
|
| Estrogens | 1 | 2021 | 1529 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2018 | 1134 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 734 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2015 | 125 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1555 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5501 | 0.030 |
Why?
|
| Apoptosis | 2 | 2023 | 9514 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2034 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2717 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3608 | 0.020 |
Why?
|
| Chromatin | 1 | 2024 | 2980 | 0.020 |
Why?
|
| Mitosis | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 164 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1673 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4893 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 1153 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2011 | 552 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6220 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5747 | 0.020 |
Why?
|
| Male | 3 | 2020 | 363698 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1377 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 898 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12240 | 0.020 |
Why?
|
| Mutation | 2 | 2024 | 30198 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2048 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2274 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12795 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 17533 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2457 | 0.020 |
Why?
|
| Virus Replication | 1 | 2014 | 2447 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4331 | 0.020 |
Why?
|
| Dependovirus | 1 | 2011 | 721 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 932 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2012 | 1087 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5929 | 0.020 |
Why?
|
| Cell Division | 1 | 2012 | 4475 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8611 | 0.010 |
Why?
|
| Cerebellum | 1 | 2011 | 1518 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2011 | 1085 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12403 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7599 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17594 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2011 | 3404 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 10033 | 0.010 |
Why?
|
| Insulin | 1 | 2015 | 6599 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 23707 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10070 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4958 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65188 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 171117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 223009 | 0.000 |
Why?
|
| Adult | 1 | 2021 | 223044 | 0.000 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_